{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:37:18Z","timestamp":1761514638786,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100017655","name":"Incyte Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017655","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s40291-020-00485-4","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T18:15:24Z","timestamp":1598984124000},"page":"593-600","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of Droplet Digital PCR versus qPCR Measurements on the International Scale for the Molecular Monitoring of Chronic Myeloid Leukemia Patients"],"prefix":"10.1007","volume":"24","author":[{"given":"Alicia Arenas","family":"Cort\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Olmedillas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juana","family":"Serrano-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2726-1193","authenticated-orcid":false,"given":"Daniel","family":"Lainez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"I\u00f1iguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Lopez-Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Atance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo Nieves Salgado","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Blas","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano Garc\u00eda","family":"Arranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar Llamas","family":"Sillero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6233-5912","authenticated-orcid":false,"given":"Juan Manuel","family":"Alonso-Dominguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"issue":"Suppl 2","key":"485_CR1","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1007\/s00277-015-2325-z","volume":"94","author":"B Chereda","year":"2015","unstructured":"Chereda B, Melo JV. Natural course and biology of CML. Ann Hematol. 2015;94(Suppl 2):S107\u201321.","journal-title":"Ann Hematol"},{"key":"485_CR2","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/S0140-6736(13)62120-0","volume":"385","author":"JF Apperley","year":"2015","unstructured":"Apperley JF. Chronic myeloid leukaemia. Lancet Lond Engl. 2015;385:1447\u201359.","journal-title":"Lancet Lond Engl."},{"key":"485_CR3","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"BJ Druker","year":"2006","unstructured":"Druker BJ, Guilhot F, O\u2019Brien SG, Gathmann I, Kantarjian H, Gattermann N, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006;355:2408\u201317.","journal-title":"N Engl J Med"},{"key":"485_CR4","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1182\/blood-2008-04-150680","volume":"112","author":"S Branford","year":"2008","unstructured":"Branford S, Fletcher L, Cross NCP, M\u00fcller MC, Hochhaus A, Kim D-W, et al. Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. Blood. 2008;112:3330\u20138.","journal-title":"Blood"},{"key":"485_CR5","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1182\/blood-2010-06-291641","volume":"116","author":"HE White","year":"2010","unstructured":"White HE, Matejtschuk P, Rigsby P, Gabert J, Lin F, Lynn Wang Y, et al. Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA. Blood. 2010;116:e111\u20137.","journal-title":"Blood"},{"key":"485_CR6","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1038\/leu.2016.90","volume":"30","author":"NCP Cross","year":"2016","unstructured":"Cross NCP, White HE, Ernst T, Welden L, Dietz C, Saglio G, et al. Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale. Leukemia. 2016;30:1844\u201352.","journal-title":"Leukemia"},{"key":"485_CR7","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","volume":"122","author":"M Baccarani","year":"2013","unstructured":"Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF, et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood. 2013;122:872\u201384.","journal-title":"Blood"},{"issue":"Suppl 2","key":"485_CR8","doi-asserted-by":"publisher","first-page":"S219","DOI":"10.1007\/s00277-015-2315-1","volume":"94","author":"NCP Cross","year":"2015","unstructured":"Cross NCP, Hochhaus A, M\u00fcller MC. Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization. Ann Hematol. 2015;94(Suppl 2):S219\u201325.","journal-title":"Ann Hematol"},{"key":"485_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-4939-0733-5_4","volume":"1160","author":"F Bizouarn","year":"2014","unstructured":"Bizouarn F. Introduction to digital PCR. Methods Mol Biol Clifton NJ. 2014;1160:27\u201341.","journal-title":"Methods Mol Biol Clifton NJ."},{"key":"485_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bdq.2014.06.001","volume":"1","author":"AA Morley","year":"2014","unstructured":"Morley AA. Digital PCR: a brief history. Biomol Detect Quantif. 2014;1:1\u20132.","journal-title":"Biomol Detect Quantif."},{"key":"485_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2164-10-116","volume":"10","author":"RA White","year":"2009","unstructured":"White RA, Blainey PC, Fan HC, Quake SR. Digital PCR provides sensitive and absolute calibration for high throughput sequencing. BMC Genomics. 2009;10:116.","journal-title":"BMC Genomics."},{"key":"485_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jmoldx.2013.10.007","volume":"16","author":"LJ Jennings","year":"2014","unstructured":"Jennings LJ, George D, Czech J, Yu M, Joseph L. Detection and quantification of BCR-ABL1 fusion transcripts by droplet digital PCR. J Mol Diagn JMD. 2014;16:174\u20139.","journal-title":"J Mol Diagn JMD."},{"key":"485_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jmoldx.2018.08.012","volume":"21","author":"J Maier","year":"2019","unstructured":"Maier J, Lange T, Cross M, Wildenberger K, Niederwieser D, Franke G-N. Optimized digital droplet PCR for BCR-ABL. J Mol Diagn JMD. 2019;21:27\u201337.","journal-title":"J Mol Diagn JMD."},{"key":"485_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/ejh.13084","volume":"101","author":"W-J Wang","year":"2018","unstructured":"Wang W-J, Zheng C-F, Liu Z, Tan Y-H, Chen X-H, Zhao B-L, et al. Droplet digital PCR for BCR\/ABL(P210) detection of chronic myeloid leukemia: a high sensitive method of the minimal residual disease and disease progression. Eur J Haematol. 2018;101:291\u20136.","journal-title":"Eur J Haematol"},{"key":"485_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1373\/clinchem.2016.262824","volume":"63","author":"M Alikian","year":"2017","unstructured":"Alikian M, Whale AS, Akiki S, Piechocki K, Torrado C, Myint T, et al. RT-qPCR and RT-digital PCR: a comparison of different platforms for the evaluation of residual disease in chronic myeloid leukemia. Clin Chem. 2017;63:525\u201331.","journal-title":"Clin Chem"},{"key":"485_CR16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jmoldx.2018.03.002","volume":"20","author":"N Coccaro","year":"2018","unstructured":"Coccaro N, Anelli L, Zagaria A, Casieri P, Tota G, Orsini P, et al. Droplet digital PCR is a robust tool for monitoring minimal residual disease in adult Philadelphia-positive acute lymphoblastic leukemia. J Mol Diagn JMD. 2018;20:474\u201382.","journal-title":"J Mol Diagn JMD."},{"key":"485_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/ejh.13238","volume":"103","author":"L Kjaer","year":"2019","unstructured":"Kjaer L, Skov V, Andersen MT, Aggerholm A, Clair P, Gniot M, et al. Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay. Eur J Haematol. 2019;103:26\u201334.","journal-title":"Eur J Haematol"},{"key":"485_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jmoldx.2019.08.007","volume":"22","author":"G-N Franke","year":"2020","unstructured":"Franke G-N, Maier J, Wildenberger K, Cross M, Giles FJ, Muller MC, et al. Comparison of real-time quantitative PCR and digital droplet PCR for BCR-ABL1 monitoring in patients with chronic myeloid leukemia. J Mol Diagn JMD. United States. 2020;22:81\u20139.","journal-title":"J Mol Diagn JMD. United States"},{"key":"485_CR19","unstructured":"Delgado Rodr\u00edguez Miguel, Llorca D\u00edaz Javier DMJM. Estudios para pruebas diagn\u00f3sticas y factores pron\u00f3sticos. Signo, editor. Barcelona; 2012."},{"key":"485_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3343\/alm.2020.40.1.72","volume":"40","author":"HJ Chung","year":"2020","unstructured":"Chung HJ, Hur M, Yoon S, Hwang K, Lim HS, Kim H, et al. Performance evaluation of the QXDx BCR-ABL %IS droplet digital PCR assay. Ann Lab Med. 2020;40:72\u20135.","journal-title":"Ann Lab Med."},{"key":"485_CR21","first-page":"5139","volume":"18","author":"Z Yan","year":"2019","unstructured":"Yan Z, Sun Q, Zhang H, Han Y, Qiao J, Niu M, et al. Advantages of digital PCR in the detection of low abundance BCR-ABL1 gene in patients with chronic myeloid leukemia. Oncol Lett. 2019;18:5139\u201344.","journal-title":"Oncol Lett."},{"key":"485_CR22","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","volume":"17","author":"J Gabert","year":"2003","unstructured":"Gabert J, Beillard E, van der Velden VHJ, Bi W, Grimwade D, Pallisgaard N, et al. Standardization and quality control studies of \u201creal-time\u201d quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia\u2014a Europe Against Cancer program. Leukemia. 2003;17:2318\u201357.","journal-title":"Leukemia"},{"key":"485_CR23","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1038\/sj.leu.2403136","volume":"17","author":"E Beillard","year":"2003","unstructured":"Beillard E, Pallisgaard N, van der Velden VHJ, Bi W, Dee R, van der Schoot E, et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u201creal-time\u201d quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)\u2014a Europe against cancer program. Leukemia. 2003;17:2474\u201386.","journal-title":"Leukemia"},{"key":"485_CR24","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/leu.2015.29","volume":"29","author":"NCP Cross","year":"2015","unstructured":"Cross NCP, White HE, Colomer D, Ehrencrona H, Foroni L, Gottardi E, et al. Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia. Leukemia. 2015;29:999\u20131003.","journal-title":"Leukemia"},{"key":"485_CR25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55:611\u201322.","journal-title":"Clin Chem"},{"key":"485_CR26","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1373\/clinchem.2013.206375","volume":"59","author":"JF Huggett","year":"2013","unstructured":"Huggett JF, Foy CA, Benes V, Emslie K, Garson JA, Haynes R, et al. The digital MIQE guidelines: minimum Information for Publication of Quantitative Digital PCR Experiments. Clin Chem. 2013;59:892\u2013902.","journal-title":"Clin Chem"},{"key":"485_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159\u201374.","journal-title":"Biometrics"},{"key":"485_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/096228029900800204","volume":"8","author":"JM Bland","year":"1999","unstructured":"Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8:135\u201360.","journal-title":"Stat Methods Med Res"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-020-00485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-020-00485-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-020-00485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:36:30Z","timestamp":1630456590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-020-00485-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["485"],"URL":"https:\/\/doi.org\/10.1007\/s40291-020-00485-4","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"type":"print","value":"1177-1062"},{"type":"electronic","value":"1179-2000"}],"subject":[],"published":{"date-parts":[[2020,9,1]]},"assertion":[{"value":"1 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded by Incyte S.L.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Juan Manuel Alonso-Dominguez received research funding from Incyte Corporation, Pfizer International and Celgene International. AAR, SO, JSL, DLG, TC, RI, JLLL, AG, MA, RNSS, CBL, MGA, and PLS have no conflicts to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The protocol was approved by the Ethics Committee for Clinical Research of the institution (FJD-HEMPCR-16-01). Informed consent was not required according to the Ethics Committee for Clinical Research of the institution.\u00a0Samples were collected in accordance with the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors consent to the publication of the current version of this work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}